{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T17:26:41Z","timestamp":1788283601267,"version":"build-2803163510"},"reference-count":117,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T00:00:00Z","timestamp":1601424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010621","name":"Uniwersytet Medyczny w Lublinie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2020.541802","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T08:39:11Z","timestamp":1601455151000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["Neurosteroids and Seizure Activity"],"prefix":"10.3389","volume":"11","author":[{"given":"Barbara","family":"Miziak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Chro\u015bci\u0144ska-Krawczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanis\u0142aw J.","family":"Czuczwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,9,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S0140-6736(18)32596-0","article-title":"Epilepsy in adults","author":"Thijs","year":"2019","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14737175.2020.1713100","article-title":"Avoiding complacency when treating uncontrolled seizures: why and how","volume":"15","author":"Amin","year":"2020","journal-title":"Expert Rev Neurother"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/1343650","article-title":"ABCB1 Polymorphisms and drug-resistant epilepsy in a Tunisian population","volume":"2019","author":"Chouchi","year":"2019","journal-title":"Dis Markers"},{"key":"B4","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/epi.16409","article-title":"Responsive neurostimulation for regional neocortical epilepsy","volume":"61","author":"Ma","year":"2020","journal-title":"Epilepsia"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1517\/17460441.2016.1154840","article-title":"Exploring the latest avenues for antiepileptic drug discovery and development","volume":"11","author":"\u0141ukawski","year":"2016","journal-title":"Expert Opin Drug Discovery"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2018.1500895","article-title":"A viewpoint on rational and irrational fixed-drug combinations","volume":"11","author":"B\u0142aszczyk","year":"2018","journal-title":"Expert Rev Clin Pharmacol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2004.11.001","article-title":"Steroids, neuroactive steroids and neurosteroids in psychopathology","volume":"29","author":"Dubrovsky","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B8","article-title":"The role of neurosteroids in the central nervous system function. [Article in Polish]","volume":"62","author":"Basta-Kaim","year":"2005","journal-title":"Przegl Lek"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/frne.1999.0188","article-title":"Neurosteroids: biosynthesis and function of these novel neuromodulators","volume":"21","author":"Compagnone","year":"2000","journal-title":"Front Neuroendocrinol"},{"key":"B10","doi-asserted-by":"crossref","DOI":"10.55782\/ane-2006-1624","article-title":"Effects of neurosteroids on neuronal survival: molecular basis and clinical perspectives","volume":"66","author":"Le\u015bkiewicz","year":"2006","journal-title":"Acta Neurobiol Exp (Wars)"},{"key":"B11","article-title":"[Perspectives of neurosteroid derivative application in antiepileptic therapy]. [Article in Polish]","volume":"62","author":"Borowicz","year":"2005","journal-title":"Przegl Lek"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2013.00115","article-title":"Role of hormones and neurosteroids in epileptogenesis","volume":"7","author":"Reddy","year":"2013","journal-title":"Front Cell Neurosci"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2015.09.008","article-title":"On the anticonvulsant effect of allopregnanolone (a neurosteroid) in neonatal rats","volume":"143","author":"Dhir","year":"2015","journal-title":"Life Sci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.seizure.2018.08.004","article-title":"Novel drugs and early polypharmacotherapy in status epilepticus","volume":"68","author":"Amengual-Gual","year":"2019","journal-title":"Seizure"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00169","article-title":"Neurosteroid actions in memory and neurologic\/neuropsychiatric disorders","volume":"10","author":"Ratner","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2006.07.031","article-title":"Sulfated steroids as endogenous neuromodulators","volume":"84","author":"Gibbs","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/bs.vh.2017.12.001","article-title":"GABA-A receptors mediate tonic inhibition and neurosteroid sensitivity in the brain","volume":"107","author":"Reddy","year":"2018","journal-title":"Vitam Horm"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(98)00034-X","article-title":"Proconvulsant effects of neurosteroids pregnenolone sulfate and dehydroepiandrosterone sulfate in mice","volume":"345","author":"Reddy","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2004.05.009","article-title":"Pregnenolone sulfate potentiates the effects of NMDA on hippocampal alanine and dopamine","volume":"78","author":"Maciejak","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.81.125","article-title":"Neuroactive neurosteroids as endogenous effectors for the sigma1 (sigma1) receptor: pharmacological evidence and therapeutic opportunities","volume":"81","author":"Maurice","year":"1999","journal-title":"Jpn J Pharmacol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.9.3774","article-title":"Neurosteroids, via sigma receptors, modulate the [3H]norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus","volume":"92","author":"Monnet","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2011.11.002","article-title":"Progesterone inhibition of neuronal calcium signaling underlies aspects of progesterone-mediated neuroprotection","volume":"131","author":"Luoma","year":"2012","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.5698\/1535-7597-16.1.31","article-title":"Epileptogenesis: more than just the latent period","volume":"16","author":"Maguire","year":"2016","journal-title":"Epilepsy Curr"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/jne.12063","article-title":"Neurosteroids and epileptogenesis","volume":"25","author":"Biagini","year":"2013","journal-title":"J Neuroendocrinol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2006.06.005","article-title":"Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function","volume":"27","author":"Papadopoulos","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2012.05.024","article-title":"Finasteride inhibits the disease-modifying activity of progesterone in the hippocampus kindling model of epileptogenesis","volume":"25","author":"Samba Reddy","year":"2012","journal-title":"Epilepsy Behav"},{"key":"B27","first-page":"3","article-title":"The antagonism between anesthetic steroid hormones and pentamethylenetetrazol (Metrazol)","volume":"27","author":"Selye","year":"1942","journal-title":"J Lab Clin Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0920-1211(98)00004-7","article-title":"Evaluation of the anticonvulsant profile of progesterone in male amygdala-kindled rats","volume":"30","author":"Mohammad","year":"1998","journal-title":"Epilepsy Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2006.05.005","article-title":"The anticonvulsant effects of progesterone and its metabolites on amygdala-kindled seizures in male rats","volume":"1101","author":"Lonsdale","year":"2006","journal-title":"Brain Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.neuroscience.2013.10.074","article-title":"Novel anticonvulsive effects of progesterone in a mouse model of hippocampal electrical kindling","volume":"257","author":"Jeffrey","year":"2014","journal-title":"Neuroscience"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/s0920-1211(01)00277-7","article-title":"The ovarian hormones and absence epilepsy: a long-term EEG study and pharmacological effects in a genetic absence epilepsy model","volume":"46","author":"van Luijtelaar","year":"2001","journal-title":"Epilepsy Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/s0306-4530(99)00068-2","article-title":"Anti-seizure effects of progesterone and 3alpha, 5alpha-THP in kainic acid and perforant pathway models of epilepsy","volume":"25","author":"Frye","year":"2000","journal-title":"Psychoneuroendocrinology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0006-8993(75)90880-x","article-title":"The metabolic clearance rate, head and brain extractions, and brain distribution and metabolism of progesterone in the anesthetized, female monkey (Macaca mulatta)","volume":"94","author":"Billiar","year":"1975","journal-title":"Brain Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1210\/endo-98-1-164","article-title":"Uptake of (3H)progesterone and (3H)5alphadihydroprogesterone by rat tissues in vivo and analysis of accumulated radioactivity: accumulation of 5alpha-dihydroprogesterone by pituitary and hypothalamic tissues","volume":"98","author":"Karavolas","year":"1976","journal-title":"Endocrinology"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2018.07.022","article-title":"The anti-seizure effects of IV 5\u03b1-dihydroprogesterone on amygdala-kindled seizures in rats","volume":"146","author":"Wu","year":"2018","journal-title":"Epilepsy Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(96)00035-4","article-title":"Effects of neurosteroid and benz[e]indene enantiomers on GABAA receptors in cultured hippocampal neurons and transfected HEK-293 cells","volume":"35","author":"Zorumski","year":"1996","journal-title":"Neuropharmacology"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1358\/mf.2009.31.7.1415891","article-title":"Effect of various antiepileptic drugs in a pentylenetetrazol-induced seizure model in mice","volume":"31","author":"Akula","year":"2009","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.14550","article-title":"Low levels of progesterone and derivatives in cerebrospinal fluid of patients affected by status epilepticus","volume":"147","author":"Meletti","year":"2018","journal-title":"J Neurochem"},{"key":"B39","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.bbr.2012.11.043","article-title":"Alteration of neonatal allopregnanolone levels affects exploration, anxiety, aversive learning and adult behavioural response to intrahippocampal neurosteroids","volume":"241","author":"M\u00f2dol","year":"2013","journal-title":"Behav Brain Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awr200","article-title":"Impaired neurosteroid synthesis in multiple sclerosis","volume":"134","author":"Noorbakhsh","year":"2011","journal-title":"Brain"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2005.22.106","article-title":"The neurosteroids progesterone and allopregnanolone reduce cell death, gliosis, and functional deficits after traumatic brain injury in rats","volume":"22","author":"Djebaili","year":"2005","journal-title":"J\u00a0Neurotrauma"},{"key":"B42","article-title":"Endogenous neuroprotective factors: neurosteroids","volume":"58","author":"Wojtal","year":"2006","journal-title":"Pharmacol Rep"},{"key":"B43","article-title":"Pseudo-epileptic seizures in children are not associated with enhanced plasma level of allopregnanolone","volume":"59","author":"Kaci\u0144ski","year":"2007","journal-title":"Pharmacol Rep"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2017.04.020","article-title":"Allopregnanolone decreases interictal spiking and fast ripples in an animal model of mesial temporal lobe epilepsy","volume":"121","author":"L\u00e9vesque","year":"2017","journal-title":"Neuropharmacology"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1111\/epi.12289","article-title":"Neuroactive steroids for the treatment of status epilepticus","author":"Rogawski","year":"2013","journal-title":"Epilepsia"},{"key":"B46","article-title":"Allopregnanolone and pregnanolone are reduced in the hippocampus of epileptic rats, but only allopregnanolone correlates with the seizure frequency","volume-title":"Neuroendocrinology","author":"Lucchi","year":"2020"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13625","article-title":"Decreased allopregnanolone levels in cerebrospinal fluid obtained during status epilepticus","volume":"58","author":"Meletti","year":"2017","journal-title":"Epilepsia"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.408","article-title":"First-in-man allopregnanolone use in super-refractory status epilepticus","volume":"4","author":"Vaitkevicius","year":"2017","journal-title":"Ann Clin Transl Neurol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0074-7742(02)49014-9","article-title":"Neurosteroids and infantile spasms: the deoxycorticosterone hypothesis","volume":"49","author":"Rogawski","year":"2002","journal-title":"Int Rev Neurobiol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(98)00629-3","article-title":"Neuroactive steroids exacerbate gamma-hydroxybutyric acid-induced absence in rats","volume":"359","author":"Banerjee","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.nurt.2006.11.003","article-title":"Ganaxolone","volume":"4","author":"Nohria","year":"2007","journal-title":"Neurotherapeutics"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-013-3276-5","article-title":"Neurosteroid interactions with synaptic and extrasynaptic GABA(A) receptors: regulation of subunit plasticity, phasic and tonic inhibition, and neuronal network excitability","volume":"230","author":"Carver","year":"2013","journal-title":"Psychopharmacol (Berl)"},{"key":"B53","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.phrs.2015.12.011","article-title":"Do traditional anti-seizure drugs have a future? A review of potential antiseizure drugs in clinical development","volume":"104","author":"Zaccara","year":"2016","journal-title":"Pharmacol Res"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1358\/dof.2004.029.03.793135","article-title":"Ganaxolone: a prospective overview","volume":"29","author":"Reddy","year":"2004","journal-title":"Drugs Future"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/s0028-3908(99)00190-2","article-title":"Acute and chronic effects of the synthetic neuroactive steroid, ganaxolone, against the convulsive and lethal effects of pentylenetetrazol in seizure-kindled mice: comparison with diazepam and valproate","volume":"39","author":"Gasior","year":"2000","journal-title":"Neuropharmacology"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2010.01.009","article-title":"Ganaxolone suppression of behavioral and electrographic seizures in the mouse amygdala kindling model","volume":"89","author":"Reddy","year":"2010","journal-title":"Epilepsy Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2009.12.037","article-title":"Anticonvulsant doses of ganaxolone do not compromise motor performance in immature rats","volume":"469","author":"Mares","year":"2010","journal-title":"Neurosci Lett"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2006.02.011","article-title":"Effects of some neurosteroids injected into some brain areas of WAG\/Rij rats, an animal model of generalized absence epilepsy","volume":"50","author":"Citraro","year":"2006","journal-title":"Neuropharmacology"},{"key":"B59","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.eplepsyres.2010.09.001","article-title":"Progress report on new antiepileptic drugs: a summary of the Tenth Eilat Conference (EILAT X)","volume":"92","author":"Bialer","year":"2010","journal-title":"Epilepsy Res"},{"key":"B60","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.eplepsyres.2012.10.001","article-title":"Progress report on new antiepileptic drugs: a summary of the Eleventh Eilat Conference (EILAT XI)","volume":"103","author":"Bialer","year":"2013","journal-title":"Epilepsy Res"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13705","article-title":"Randomized, double-blind, placebo-controlled phase 2 study of ganaxolone as add-on therapy in adults with uncontrolled partial-onset seizures","volume":"58","author":"Sperling","year":"2017","journal-title":"Epilepsia"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aeh125","article-title":"The interaction of anaesthetic steroids with recombinant glycine and GABAA receptors","volume":"92","author":"Weir","year":"2004","journal-title":"Br J Anaesth"},{"key":"B63","volume-title":"Neurosteroids: endogenous modulators of seizures susceptibility:\u00a0in\u00a0Epilepsy: Scientific Foundations of Clinical Practive.","author":"Rogawski","year":"2004"},{"key":"B64","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0924-977X(97)00037-0","article-title":"Protective effects of neurosteroids against NMDA-induced seizures and lethality in mice","volume":"8","author":"Budziszewska","year":"1998","journal-title":"Eur J Neuropsychopharmacol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0014-2999(02)01975-1","article-title":"Interaction of the neurosteroid alphaxalone with conventional antiepileptic drugs in different types of experimental seizures","volume":"449","author":"Borowicz","year":"2002","journal-title":"Eur J\u00a0Pharmacol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.119.261735","article-title":"Isobolographic analysis of antiseizure activity of the GABA-A receptor-modulating synthetic neurosteroids brexanolone and ganaxolone with tiagabine and midazolam","volume":"372","author":"Chuang","year":"2020","journal-title":"J Pharmacol Exp Ther"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13999","article-title":"Intramuscular allopregnanolone and ganaxolone in a mouse model of treatment-resistant status epilepticus","author":"Zolkowska","year":"2018","journal-title":"Epilepsia"},{"key":"B68","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.brainres.2018.02.031","article-title":"Neurosteroid regulation of GABAA receptors: A role in catamenial epilepsy","volume":"1703","author":"Joshi","year":"2019","journal-title":"Brain Res"},{"key":"B69","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.seizure.2015.02.024","article-title":"Catamenial epilepsy: Update on prevalence, pathophysiology and treatment from the findings of the NIH Progesterone Treatment Trial","volume":"28","author":"Herzog","year":"2015","journal-title":"Seizure"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013225","article-title":"Treatments for seizures in catamenial (menstrual-related) epilepsy","volume":"10","author":"Maguire","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"B71","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/nn1469","article-title":"Ovarian cycle-linked changes in GABA(A) receptors mediating tonic inhibition alter seizure susceptibility and anxiety","volume":"8","author":"Maguire","year":"2005","journal-title":"Nat Neurosci"},{"key":"B72","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.nbd.2014.06.010","article-title":"Neurosteroids and their role in sex-specific epilepsies","author":"Reddy","year":"2014","journal-title":"Neurobiol Dis"},{"key":"B73","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.seizure.2018.10.012","article-title":"Progesterone, 5a-dihydropogesterone and allopregnanolone\u2019s effects on seizures: A review of animal and clinical studies","volume":"63","author":"Wu","year":"2018","journal-title":"Seizure"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1983.tb04901.x","article-title":"Effect of norethisterone on seizures associated with menstruation","volume":"24","author":"Dana-Haeri","year":"1983","journal-title":"Epilepsia"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10508","article-title":"Seizure exacerbation associated with inhibition of progesterone metabolism","volume":"53","author":"Herzog","year":"2003","journal-title":"Ann Neurol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318259e1f9","article-title":"Progesterone vs placebo therapy for women with epilepsy: A randomized clinical trial","volume":"78","author":"Herzog","year":"2012","journal-title":"Neurology"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000623","article-title":"Allopregnanolone levels and seizure frequency in progesterone-treated women with epilepsy","volume":"83","author":"Herzog","year":"2014","journal-title":"Neurology"},{"key":"B78","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/s1734-1140(13)70967-8","article-title":"Progesterone therapy in women with epilepsy","volume":"65","author":"Motta","year":"2013","journal-title":"Pharmacol Rep"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2018.08.024","article-title":"Estrogen-related seizure exacerbation following hormone therapy for assisted reproduction in women with epilepsy","volume":"61","author":"Mostacci","year":"2018","journal-title":"Seizure"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.14-12-07680.1994","article-title":"Estradiol regulates hippocampal dendritic spine density via an N-methyl-D-aspartate receptor-dependent mechanism","volume":"14","author":"Woolley","year":"1994","journal-title":"J Neurosci"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.4161-10.2010","article-title":"Estradiol acutely potentiates hippocampal excitatory synaptic transmission through a presynaptic mechanism","volume":"30","author":"Smejkalova","year":"2010","journal-title":"J\u00a0Neurosci"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X16666180628164432","article-title":"Estrogen and serotonin: Complexity of interactions and implications for epileptic seizures and epileptogenesis","volume":"17","author":"Pottoo","year":"2019","journal-title":"Curr Neuropharmacol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.2001.91.6.2785","article-title":"Invited review: Estrogens effects on the brain: multiple sites and molecular mechanisms","volume":"91","author":"McEwen","year":"2001","journal-title":"J Appl Physiol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2018.04.004","article-title":"Aromatase inhibition by letrozole attenuates kainic acid-induced seizures but not neurotoxicity in mice","volume":"143","author":"Iqbal","year":"2018","journal-title":"Epilepsy Res"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2015.10.001","article-title":"Reduced estradiol synthesis by letrozole, an aromatase inhibitor, is protective against development of pentylenetetrazole-induced kindling in mice","volume":"90","author":"Rashid","year":"2015","journal-title":"Neurochem Int"},{"key":"B86","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.psyneuen.2018.10.017","article-title":"Effects of androsterone on the protective action of various antiepileptic drugs against maximal electroshock-induced seizures in mice","volume":"101","author":"Tutka","year":"2019","journal-title":"Psychoneuroendocrinology"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.2002.7931","article-title":"Dose-, time-, age, and sex-response profiles for the anticonvulsant effects of deoxycorticosterone in 15-day-old-rats","volume":"176","author":"Edwards","year":"2002","journal-title":"Exp Neurol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2007.01.123","article-title":"Anticonvulsant actions of deoxycorticosterone","volume":"1145","author":"Perez-Cruz","year":"2007","journal-title":"Brain Res"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1111\/epi.14454","article-title":"Long-term negative impact of an inappropriate first antiepileptic medication on the efficacy of a second antiepileptic medication in mice","volume":"59","author":"Pawluski","year":"2018","journal-title":"Epilepsia"},{"key":"B90","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.neuropharm.2012.05.045","article-title":"Cation-chloride cotransporters NKCC1 and KCC2 as potential targets for novel antiepileptic and antiepileptogenic treatments","volume":"69","author":"L\u00f6scher","year":"2013","journal-title":"Neuropharmacology"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2019.02.061","article-title":"Somatostatin interneurons promote neuronal synchrony in the neonatal hippocampus","volume":"26","author":"Flossmann","year":"2019","journal-title":"Cell Rep"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3482-15.2016","article-title":"An optogenetic approach for investigation of excitatory and inhibitory network GABA actions in mice expressing channelrhodopsin-2 in GABAergic neurons","volume":"36","author":"Valeeva","year":"2016","journal-title":"J Neurosci"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1177\/1073858412438697","article-title":"The GABA excitatory\/inhibitory shift in brain maturation and neurological disorders","volume":"18","author":"Ben-Ari","year":"2012","journal-title":"Neuroscientist"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4695(19971120)33:6<781::AID-NEU6>3.0.CO;2-5","article-title":"Expression of the Na-K-2Cl cotransporter is developmentally regulated in postnatal rat brains: a possible mechanism underlying GABA\u2019s excitatory role in immature brain","volume":"33","author":"Plotkin","year":"1997","journal-title":"J\u00a0Neurobiol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1038\/nm1301","article-title":"NKCC1 transporter facilitates seizures in the developing brain","volume":"11","author":"Dzhala","year":"2005","journal-title":"Nat Med"},{"key":"B96","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.1528-1167.2007.01295.x","article-title":"Timing of the developmental switch in GABA(A) mediated signaling from excitation to inhibition in CA3 rat hippocampus using gramicidin perforated patch and extracellular recordings","author":"Tyzio","year":"2007","journal-title":"Epilepsia"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2012.03442.x","article-title":"Phasic GABAA-receptor activation is required to suppress epileptiform activity in the CA3 region of the immature rat hippocampus","volume":"53","author":"Kolbaev","year":"2012","journal-title":"Epilepsia"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1152\/jn.01022.2002","article-title":"Reduced inhibition and sensitivity to neurosteroids in hippocampus of mice lacking the GABA(A) receptor delta subunit","volume":"90","author":"Spigelman","year":"2003","journal-title":"J Neurophysiol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2019.106196","article-title":"Allopregnanolone augments epileptiform activity of an in-vitro mouse hippocampal preparation in the first postnatal week","volume":"157","author":"Sharopov","year":"2019","journal-title":"Epilepsy Res"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2005.08.008","article-title":"Anticonvulsant action of three neurosteroids against cortical epileptic afterdischarges in immature rats","volume":"68","author":"Mares","year":"2005","journal-title":"Brain Res Bull"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2006.03.009","article-title":"Anticonvulsant action of allopregnanolone in immature rats","volume":"70","author":"Mares","year":"2006","journal-title":"Epilepsy Res"},{"key":"B102","article-title":"Anticonvulsant action of a new analogue of allopregnanolone in immature rats","volume":"59","author":"Mares","year":"2010","journal-title":"Physiol Res"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuro.2007.01.014","article-title":"Extrapolating brain development from experimental species to humans","volume":"28","author":"Clancy","year":"2007","journal-title":"Neurotoxicology"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2015.09.012","article-title":"Loss of neurosteroid-mediated protection following stress during fetal life","volume":"160","author":"Hirst","year":"2016","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2006.02.012","article-title":"Deoxycorticosterone,s anticonvulsant effects in infant rats are blocked by finasteride, but not by indomethacin","volume":"200","author":"Perez-Cruz","year":"2006","journal-title":"Exp Neurol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24295","article-title":"Pediatric super-refractory status epilepticus treated with allopregnanolone","volume":"76","author":"Broomall","year":"2014","journal-title":"Ann Neurol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0920-1211(03)00042-1","article-title":"Inter-ictal and post-ictal circulating levels of allopregnanolone, an anticonvulsant metabolite of progesterone, in epileptic children","volume":"54","author":"Grosso","year":"2003","journal-title":"Epilepsy Res"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddv245","article-title":"Mutations of protocadherin 19 in female epilepsy (PCDH19-FE) lead to allopregnanolone deficiency","volume":"24","author":"Tan","year":"2015","journal-title":"J Hum Mol Genet"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13772","article-title":"Reduced steroidogenesis in patients with PCDH19-female limited epilepsy","volume":"58","author":"Trivisano","year":"2017","journal-title":"Epilepsia"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-1211(00)00170-4","article-title":"Ganaxolone for treating intractable infantile spasms: a multicenter, open-label, add-on trial","volume":"42","author":"Kerrigan","year":"2000","journal-title":"Epilepsy Res"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2007.01182.x","article-title":"Clinical evaluation of ganaxolone in pediatric and adolescent patients with refractory epilepsy","volume":"48","author":"Pieribone","year":"2007","journal-title":"Epilepsia"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2017.00246","article-title":"Ganaxolone: a new treatment for neonatal seizures","volume":"11","author":"Yawno","year":"2017","journal-title":"Front Cell Neurosci"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1007\/s007020050082","article-title":"Rimcazole, a sigma receptor ligand, and the anticonvulsive action of conventional antiepileptic drugs","volume":"105","author":"Borowicz","year":"1998","journal-title":"J Neural Transm"},{"key":"B114","first-page":"29","article-title":"Calcium modulation in epilepsy","volume":"56","author":"Ku\u0142ak","year":"2004","journal-title":"Pol J Pharmacol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2008.05538.x","article-title":"Neuroactive steroids and GABAA receptor plasticity in the brain of the WAG\/Rij rat, a model of absence epilepsy","volume":"106","author":"Pisu","year":"2008","journal-title":"J Neurochem"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2019.11.008","article-title":"New and emerging medications for treatment of pediatric epilepsy","volume":"107","author":"Perry","year":"2019","journal-title":"Pediatr Neurol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2004.01.002","article-title":"Do pediatric drugs cause developing neurons to commit suicide","volume":"25","author":"Olney","year":"2004","journal-title":"Trends Pharmacol Sci"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2020.541802\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T01:31:40Z","timestamp":1723685500000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2020.541802\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,30]]},"references-count":117,"alternative-id":["10.3389\/fendo.2020.541802"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2020.541802","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,30]]},"article-number":"541802"}}